Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$12.62 - $24.47 $552,049 - $1.07 Million
-43,744 Reduced 78.7%
11,839 $289,000
Q1 2023

May 15, 2023

BUY
$12.98 - $17.1 $546,185 - $719,550
42,079 Added 311.6%
55,583 $748,000
Q4 2022

Feb 14, 2023

SELL
$13.92 - $17.0 $84,327 - $102,986
-6,058 Reduced 30.97%
13,504 $210,000
Q3 2022

Nov 14, 2022

BUY
$13.36 - $16.75 $261,348 - $327,663
19,562 New
19,562 $293,000

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.